Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.
- DOI
- 10.1021/acs.jmedchem.6c01454
- Published
- 2026 Sep 10
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c01454,
title = {Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.},
author = {Phillips DP and Alper PB and Borkin D and Han D and Kochanek SE and Gurjar J and Mathison CJN and Nelson JM and Pei W and Nguyen BN and Hoffman T and Okram B and Nguyen TN and Jiang S and Masick BT and Wang Z and Cho CY and Yin H and Chen Y and Juarez J and Jia Y and Zhou V and Liu G and Wright C and Nguyen T and Knee DA and Liu Q and Liu J and Li J and Virata C and de Oliveira C and DiDonato M and Bursulaya B and Vidal-Biggart A and Jones DH and Witmer D and Chu C and Jin H and Herath A and Richmond W and Groessl T and Shapiro M and Effenberger K and Arroyo K and Bretz A and Honda A and Gordon WP and Molteni V and Haling JR},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c01454},
url = {https://doi.org/10.1021/acs.jmedchem.6c01454}
}RIS
TY - JOUR TI - Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure. AU - Phillips DP AU - Alper PB AU - Borkin D AU - Han D AU - Kochanek SE AU - Gurjar J AU - Mathison CJN AU - Nelson JM AU - Pei W AU - Nguyen BN AU - Hoffman T AU - Okram B AU - Nguyen TN AU - Jiang S AU - Masick BT AU - Wang Z AU - Cho CY AU - Yin H AU - Chen Y AU - Juarez J AU - Jia Y AU - Zhou V AU - Liu G AU - Wright C AU - Nguyen T AU - Knee DA AU - Liu Q AU - Liu J AU - Li J AU - Virata C AU - de Oliveira C AU - DiDonato M AU - Bursulaya B AU - Vidal-Biggart A AU - Jones DH AU - Witmer D AU - Chu C AU - Jin H AU - Herath A AU - Richmond W AU - Groessl T AU - Shapiro M AU - Effenberger K AU - Arroyo K AU - Bretz A AU - Honda A AU - Gordon WP AU - Molteni V AU - Haling JR PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c01454 UR - https://doi.org/10.1021/acs.jmedchem.6c01454 ER -
APA
DP, P., PB, A., D, B., D, H., SE, K., J, G., CJN, M., JM, N., W, P., BN, N., T, H., B, O., TN, N., S, J., BT, M., Z, W., CY, C., H, Y., Y, C., J, J., Y, J., V, Z., G, L., C, W., T, N., DA, K., Q, L., J, L., J, L., C, V., C, D. O., M, D., B, B., A, V., DH, J., D, W., C, C., H, J., A, H., W, R., T, G., M, S., K, E., K, A., A, B., A, H., WP, G., V, M., & JR, H. (2026). Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c01454
Source records
- pubmed · retrieved 2026-09-26T11:49:44.547Z